Related references
Note: Only part of the references are listed.Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders
Jan Rusz et al.
MOVEMENT DISORDERS (2021)
Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
Francesco Cavallieri et al.
FRONTIERS IN NEUROLOGY (2021)
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
Jan Rusz et al.
ANNALS OF NEUROLOGY (2021)
Glottal Source Analysis of Voice Deficits in Newly Diagnosed Drug-naive Patients with Parkinson's Disease: Correlation Between Acoustic Speech Characteristics and Non-Speech Motor Performance
Michal Novotny et al.
BIOMEDICAL SIGNAL PROCESSING AND CONTROL (2020)
Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson's disease
Tereza Tykalova et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Speech difficulties in early de novo patients with Parkinson's disease
Sotirios Polychronis et al.
PARKINSONISM & RELATED DISORDERS (2019)
Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder
Petr Dusek et al.
SCIENTIFIC REPORTS (2019)
Acoustic Tracking of Pitch, Modal, and Subharmonic Vibrations of Vocal Folds in Parkinsons Disease and Parkinsonism
Jan Hlavnicka et al.
IEEE ACCESS (2019)
Voice quality outcomes of idiopathic Parkinson's disease medical treatment: A systematic review
J. R. Lechien et al.
CLINICAL OTOLARYNGOLOGY (2018)
Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation
L. Brabenec et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease
Margherita Fabbri et al.
FRONTIERS IN NEUROLOGY (2017)
Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder
Jan Hlavnicka et al.
SCIENTIFIC REPORTS (2017)
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression
Seyed-Mohammad Fereshtehnejad et al.
BRAIN (2017)
Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients
Jan Rusz et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Age at onset and Parkinson disease phenotype
Gennaro Pagano et al.
NEUROLOGY (2016)
Speech prosody impairment predicts cognitive decline in Parkinson's disease
Irena Rektorova et al.
PARKINSONISM & RELATED DISORDERS (2016)
How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
Tanya Simuni et al.
PARKINSONISM & RELATED DISORDERS (2016)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Parkinson Disease Subtypes
Mary Ann Thenganatt et al.
JAMA NEUROLOGY (2014)
Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy
Jan Rusz et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Impairment of Vowel Articulation as a Possible Marker of Disease Progression in Parkinson's Disease
Sabine Skodda et al.
PLOS ONE (2012)
Levodopa Effects on Hand and Speech Movements in Patients with Parkinson's Disease: A fMRI Study
Audrey Maillet et al.
PLOS ONE (2012)
Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease
J. Rusz et al.
JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA (2011)
Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson's disease symptom severity
Athanasios Tsanas et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2011)
Functional Magnetic Resonance Imaging Exploration of Combined Hand and Speech Movements in Parkinson's Disease
Serge Pinto et al.
MOVEMENT DISORDERS (2011)
Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease
E. Tripoliti et al.
NEUROLOGY (2011)
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
Jacques Darcourt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease
Sabine Skodda et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
The effect of onset age on the clinical features of Parkinson's disease
M. M. Wickremaratchi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
For better or worse: The effect of levodopa on speech in Parkinson's disease
Aileen K. Ho et al.
MOVEMENT DISORDERS (2008)
The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation
Piero Calvini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): Process, format, and clinimetric testing plan
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2007)
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
A Schrag et al.
LANCET NEUROLOGY (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Laryngeal findings in advanced Parkinson's disease
JH Blumin et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2004)
Treatments for dysarthria in Parkinson's disease
S Pinto et al.
LANCET NEUROLOGY (2004)
Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT
M Visser et al.
MOVEMENT DISORDERS (2004)
Limitations of current Parkinson's disease therapy
O Rascol et al.
ANNALS OF NEUROLOGY (2003)
Share Paper
